{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:19:32Z","timestamp":1791566372749,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a proliferative arteriopathy associated with glucose transporter-1 (Glut1) up-regulation and a glycolytic shift in lung metabolism. Glycolytic metabolism can be detected with the positron emission tomography (PET) tracer 18F-fluorodeoxyglucose (FDG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The precise cell type in which glycolytic abnormalities occur in PAH is unknown. Moreover, whether FDG-PET is sufficiently sensitive to monitor PAH progression and detect therapeutic regression is untested. We hypothesized that increased lung FDG-PET reflects enhanced glycolysis in vascular cells and is reversible in response to effective therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PAH was induced in Sprague-Dawley rats by monocrotaline or chronic hypoxia (10% oxygen) in combination with Sugen 5416. Monocrotaline rats were treated with oral dichloroacetate or daily imatinib injections. FDG-PET scans and pulmonary artery acceleration times were obtained weekly. The origin of the PET signal was assessed by laser capture microdissection of airway versus vascular tissue. Metabolism was measured in pulmonary artery smooth muscle cell (PASMC) cultures, using a Seahorse extracellular flux analyzer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Lung FDG increases 1\u20132 weeks after monocrotaline (when PAH is mild) and is normalized by dichloroacetate and imatinib, which both also regress medial hypertrophy. Glut1 mRNA is up-regulated in both endothelium and PASMCs, but not airway cells or macrophages. PASMCs from monocrotaline rats are hyperproliferative and display normoxic activation of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), which underlies their glycolytic phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HIF-1\u03b1-mediated Glut1 up-regulation in proliferating vascular cells in PAH accounts for increased lung FDG-PET uptake. FDG-PET is sensitive to mild PAH and can monitor therapeutic changes in the vasculature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201108-1562oc","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T02:25:44Z","timestamp":1326421544000},"page":"670-679","source":"Crossref","is-referenced-by-count":174,"title":["Lung 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension"],"prefix":"10.1093","volume":"185","author":[{"given":"Glenn","family":"Marsboom","sequence":"first","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wietholt","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad R.","family":"Haney","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Toth","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Morrow","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenappan","family":"Thenappan","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bache-Wiig","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Piao","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Paul","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Tu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Archer","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"2026032101152790000_bib1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI23203","article-title":"Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension","volume":"115","author":"McMurtry","year":"2005","journal-title":"J Clin Invest"},{"key":"2026032101152790000_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.RES.88.6.555","article-title":"Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis","volume":"88","author":"Geraci","year":"2001","journal-title":"Circ Res"},{"key":"2026032101152790000_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","article-title":"Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline","volume":"174","author":"Thomas","year":"2009","journal-title":"Am J Pathol"},{"key":"2026032101152790000_bib4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.biocel.2008.01.028","article-title":"Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension","volume":"40","author":"Kouri","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"2026032101152790000_bib5","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/CIRCULATIONAHA.106.670026","article-title":"Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension","volume":"115","author":"Zakrzewicz","year":"2007","journal-title":"Circulation"},{"key":"2026032101152790000_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1172\/JCI1910","article-title":"Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension","volume":"101","author":"Lee","year":"1998","journal-title":"J Clin Invest"},{"key":"2026032101152790000_bib7","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI32503","article-title":"An antiproliferative BMP-2\/PPAR\u03b3\/apoE axis in human and murine SMCs and its role in pulmonary hypertension","volume":"118","author":"Hansmann","year":"2008","journal-title":"J Clin Invest"},{"key":"2026032101152790000_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/hc3201.094152","article-title":"Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-\u03b21 and bone morphogenetic proteins","volume":"104","author":"Morrell","year":"2001","journal-title":"Circulation"},{"key":"2026032101152790000_bib9","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial\u2013hypoxia inducible factor-1\u03b1\u2013Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"key":"2026032101152790000_bib10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor 1\u03b1 regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"Am J Pathol"},{"key":"2026032101152790000_bib11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.0605080104","article-title":"Alterations of cellular bioenergetics in pulmonary artery endothelial cells","volume":"104","author":"Xu","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026032101152790000_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/hc0202.101974","article-title":"Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"key":"2026032101152790000_bib13","author":"Sutendra"},{"key":"2026032101152790000_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria\u2013K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"key":"2026032101152790000_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"Hif-1\u2013mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"2026032101152790000_bib16","doi-asserted-by":"crossref","first-page":"28106","DOI":"10.1074\/jbc.M803508200","article-title":"Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance","volume":"283","author":"Lu","year":"2008","journal-title":"J Biol Chem"},{"key":"2026032101152790000_bib17","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"2026032101152790000_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1164\/rccm.200301-147OC","article-title":"Oxidative stress in severe pulmonary hypertension","volume":"169","author":"Bowers","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101152790000_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1021\/bi051402s","article-title":"Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands","volume":"45","author":"Knoechel","year":"2006","journal-title":"Biochemistry"},{"key":"2026032101152790000_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/01.RES.0000145360.16770.9f","article-title":"Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis","volume":"95","author":"McMurtry","year":"2004","journal-title":"Circ Res"},{"key":"2026032101152790000_bib21","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1096\/fj.09-131664","article-title":"Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22\u03b1-targeted overexpression of the serotonin transporter","volume":"23","author":"Guignabert","year":"2009","journal-title":"FASEB J"},{"key":"2026032101152790000_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.2002.20.2.379","article-title":"Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography","volume":"20","author":"Bos","year":"2002","journal-title":"J Clin Oncol"},{"key":"2026032101152790000_bib23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jacc.2005.02.065","article-title":"Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol","volume":"45","author":"Oikawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026032101152790000_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","article-title":"The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle","volume":"88","author":"Piao","year":"2010","journal-title":"J Mol Med"},{"key":"2026032101152790000_bib25","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","article-title":"Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure","volume":"297","author":"Stenmark","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026032101152790000_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-1241.2011.02710.x","article-title":"Rodent models of pulmonary hypertension: Harmonisation with the World Health Organisation's categorisation of human PH","volume":"65","author":"Ryan","year":"2011","journal-title":"Int J Clin Pract"},{"key":"2026032101152790000_bib27","author":"Taraseviciene-Stewart"},{"key":"2026032101152790000_bib28","doi-asserted-by":"crossref","first-page":"L401","DOI":"10.1152\/ajplung.00114.2010","article-title":"Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension","volume":"299","author":"Urboniene","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026032101152790000_bib29","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"key":"2026032101152790000_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","article-title":"Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage","volume":"168","author":"Frid","year":"2006","journal-title":"Am J Pathol"},{"key":"2026032101152790000_bib31","doi-asserted-by":"crossref","first-page":"L202","DOI":"10.1152\/ajplung.2001.281.1.L202","article-title":"Partial HIF-1\u03b1 deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia","volume":"281","author":"Shimoda","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026032101152790000_bib32","first-page":"146","author":"Nakajo","year":"2012"},{"key":"2026032101152790000_bib33","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1074\/jbc.M010144200","article-title":"Regulation of Glut1 mRNA by hypoxia-inducible factor-1: interaction between h-Ras and hypoxia","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"2026032101152790000_bib34","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"2026032101152790000_bib35","doi-asserted-by":"crossref","first-page":"L753","DOI":"10.1152\/ajplung.00286.2010","article-title":"p53 gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice","volume":"300","author":"Mizuno","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/6\/670\/67292672\/ajrccm_185_6_670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/6\/670\/67292672\/ajrccm_185_6_670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:15:38Z","timestamp":1774070138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/185\/6\/670\/8508062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,15]]},"published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201108-1562oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3]]}}}